Insider Selling: CryoPort, Inc. (NASDAQ:CYRX) CEO Sells 151,304 Shares of Stock

CryoPort, Inc. (NASDAQ:CYRX - Get Free Report) CEO Jerrell Shelton sold 151,304 shares of the firm's stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $6.81, for a total value of $1,030,380.24. Following the completion of the transaction, the chief executive officer now owns 912,419 shares in the company, valued at $6,213,573.39. The trade was a 14.22% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Jerrell Shelton also recently made the following trade(s):

• On Wednesday, June 18th, Jerrell Shelton sold 119,281 shares of CryoPort stock. The shares were sold at an average price of $6.81, for a total value of $812,303.61.
• On Friday, June 20th, Jerrell Shelton sold 69,135 shares of CryoPort stock. The shares were sold at an average price of $6.47, for a total value of $447,303.45.
• On Monday, March 24th, Jerrell Shelton sold 2,980 shares of CryoPort stock. The shares were sold at an average price of $6.94, for a total value of $20,681.20.

CryoPort Trading Down 6.0%

Shares of NASDAQ:CYRX traded down $0.41 during midday trading on Friday, reaching $6.37. 607,870 shares of the company's stock were exchanged, compared to its average volume of 532,638. The firm's 50 day simple moving average is $6.19 and its two-hundred day simple moving average is $6.72. The company has a debt-to-equity ratio of 0.51, a current ratio of 5.56 and a quick ratio of 5.24. The stock has a market cap of $319.39 million, a price-to-earnings ratio of -2.72 and a beta of 1.85. CryoPort, Inc. has a fifty-two week low of $4.58 and a fifty-two week high of $9.93.

CryoPort (NASDAQ:CYRX - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The firm had revenue of $41.04 million during the quarter, compared to the consensus estimate of $56.19 million. CryoPort had a negative return on equity of 11.03% and a negative net margin of 50.15%. As a group, sell-side analysts forecast that CryoPort, Inc. will post -0.99 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Roth Mkm reiterated a "buy" rating and set a $15.00 price target on shares of CryoPort in a report on Tuesday, April 1st. Needham & Company LLC reiterated a "buy" rating and set a $11.00 price target on shares of CryoPort in a report on Thursday, May 8th. Morgan Stanley reduced their price target on CryoPort from $8.00 to $7.00 and set an "equal weight" rating on the stock in a report on Monday, May 5th. UBS Group lifted their price target on CryoPort from $10.00 to $11.00 and gave the stock a "buy" rating in a report on Tuesday, April 1st. Finally, Guggenheim reiterated a "buy" rating and set a $10.00 price target on shares of CryoPort in a report on Wednesday, April 16th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $11.00.

Institutional Trading of CryoPort

A number of hedge funds and other institutional investors have recently modified their holdings of CYRX. Cadian Capital Management LP increased its position in shares of CryoPort by 14.1% during the 4th quarter. Cadian Capital Management LP now owns 4,927,027 shares of the company's stock worth $38,332,000 after purchasing an additional 609,021 shares during the last quarter. Millennium Management LLC increased its position in shares of CryoPort by 11.0% during the 4th quarter. Millennium Management LLC now owns 4,139,869 shares of the company's stock worth $32,208,000 after purchasing an additional 409,353 shares during the last quarter. LPL Financial LLC increased its position in shares of CryoPort by 1,366.1% during the 4th quarter. LPL Financial LLC now owns 436,766 shares of the company's stock worth $3,398,000 after purchasing an additional 406,976 shares during the last quarter. Norges Bank acquired a new stake in shares of CryoPort during the 4th quarter worth about $2,711,000. Finally, Silvercrest Asset Management Group LLC increased its position in shares of CryoPort by 77.0% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 742,914 shares of the company's stock worth $5,780,000 after purchasing an additional 323,216 shares during the last quarter. 92.90% of the stock is owned by institutional investors and hedge funds.

CryoPort Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.